S q Udesanding the extent to which hildhood leukaemia and non-Hodgkin lymphomas are heritable is important to the survivors of these diseases, their familis and clnicians who provide genetic counsling Such understanding is also relevant to the possibiity raised by Gardner et al. (1990, Br. Med J., 360, 423-429) 
is of great importance to survivors of these diseases, their families and the clinicians who provide genetic counselling. This information is also relevant to the question of whether paternal preconception irradiation is involved in the aetiology of childhood lukaemia and non-Hodgkin lymphomas (Gardner et al., 1990) .
Malignant neoplasms occur rarely in childhood -there are 1200 newly diagnosed patients aged under 15 each year in Bntain. During recent decades there have been considerable improvements in the proportion of patients surviving at least 5 years from diagnosis, and about 90% of such survivors appear cured (Robertson et al., 1994 (Pearson and Hartley, 1976 (Knudson, 1993) . For the majority of such syndromes identified, the molcular mechanism involves tumour-suppressor genes (Knudson, 1993) . There is evidence that this mechanism is involved in the development of leukaemias associated with the Li-Fraumeni syndrome (Malk-in, 1993) . We investigate the implications of assuming that a proportion of leukaemia and non-Hodgkin lymphoma survivors have a heritable form of these diseases and that these are transmitted as an autosomal dominant with specified penetrance. In the statistical appendix we develop an expression for the probability of the observed data on the offspring under these assumptions. Using this expression we may obtain an upper (one-sided) confidence bound for the proportion of survivors with the heritable form of leukaemia or non-Hodgkin lymphoma.
We compared the observed numbers of serious (ie potentially lethal or handicapping congenital abnormalities occurring among offspring with those expected from some of the most reliable sources of birth prevalence available in Britain, and compiled by Leck (1994 No malignant neoplasms occurred among the offspring. The expected number based on rates of these diseases in the general population was 0.36, which gives an upper (onesided) 95% confidence bound on the relative risk of malignant neoplasms among the offspring of 8.4. The expected number of leukaemias and non-Hodgkin lymphomas was 0.14: this givesan upper (one-sided) 95% confidence bound on the relative risk of leukaemia or non-Hodgkin lymphomas among the offspring of 21.4. The latter confidence bound is high but is determined by the small number of offspring available and the rarity with which these dieases are expected to occur.
In Table I we give the upper (one-sided) 95% and 99% confidence bounds for the proportion of survivors with heritable leukaemia or non-Hodgkin lymphoma on the assumption that the mode of inheritance is that of a simple dominant gene with the indicated level of penetrance. Separate confidence bounds are given depending on whether it is assumed that all heritable cases will appear by age 15 years or by age 50 years. If we assume that all such cases manifest by age 15, then, if the diseases had a penetrance of at least 0.7, the proportion of heritable cases among the survivors is unlikely to exceed 5%.
In Table H we give the observed and expected numbers of deaths among the offspring. There was one death from a congenital abnormality: a tracheo-oesophageal fistula. None of the remaimnng six deaths was due to a neoplasm or congenital abnormality. Two deaths were due to pneumonia in offspring with pre-existing brain damage. three to complications of a premature delivery and one to a severe head injury: the circumstances in which this arose are not specified. Investigation of the congenital abnormalities occurring among the offspring indicated that the observed frequency of serious abnormalities was broadly similar to that expected (Leck. 1994). However. there were four offspring. of different parents. who were diagnosed with pyloric stenosis. If we take the prevalence at birth as between 3 and 5 per 1000 total births (Leck, 1994) then the expected number lies between 382 x 0.003 = 1.15 and 382 x 0.005 = 1.91. Assuming underlying Poisson variability then the one-tailed P-values associated with these expected numbers are 0.03 and 0.13 respectively. Therefore, the observed number is not sufficiently discrepant from that expected to conclude that there is evidence of an excess. Table III summarises the sex of offspring in relation to the sex of their parents. There was some evidence of an excess of male offspring born to female survivors when compared with the sex ratio in the general population (P = 0.06. two-tailed test) (Office of Population Censuses and Surveys, 1991) . Although this excess was apparent among the offspring of both leukaemia and non-Hodgkin lymphoma survivors separately, it may well be due to chance, and further interpretation is not justified without independent confirmation. It is of interest that in a previous study Fraumeni (1964) reported that only 24 of 56 offspring of mothers diagnosed with leukaemia. mainly acute myeloid. were male. Harnden (1985) has concluded that the evidence that inherited factors are important in the aetiology of leukaemia and lymphoma is not strong. In a recent review of the natural history of childhood acute leukaemia Greaves (1993) has concluded that: 'inherited abnormal alleles are likely to play a part in childhood leukaemia: their actual contribution may well be relatively small but is almost certainly underestimated at present'. The most direct way to estimate the extent of the inherited component of childhood leukaemia and non-Hodgkin lymphoma is to study the frequency of occurrence of these diseases among the offspring of patients who survive. This is not entirely without problems of interpretation since it might be that the group of patients who survive and produce offspring may contain a different proportion of henrtable cases to those originally diagnosed. If we assume that such selection does not take place. then from Table I it is apparent that, assuming that all heritable cases occur by age 15 years, the proportion of survivors with the heritable form of leukaemia and non-Hodgkin lymphoma is unlikely to exceed 5%. This also assumes that the pattern of inheritance is that of an autosomal dominant gene with penetrance of at least 0.7. A critical assumption underlying the derivation of the upper confidence bound on the proportion of heritable cases is that the age distribution for the heritable cases is proportionate to that for sporadic cases (see the statistical appendix). This is unlikely to be true. However, experience from retinoblastoma indicates that heritable cases develop at younger ages than sporadic cases (Draper et al.. 1992) . and it is reasonable to assume the same would apply to heritable leukaemia and non-Hodgkin lymphomas. On this basis the upper confidence bound we have estimated will almost certainly be too large. although by how much is unknown because of uncertainty relating to the true age distribution of the heritable cases.
The heritability of childhood leukaemia and non-Hodgkin lymphoma has assumed considerable importance as an occupational and public health issue as a result of the suggestion that paternal preconceptual occupational exposure to radiation at the Sellafield nuclear reprocessing plant may be involved in the development of these diseases (Gardner et al.. 1990 ). Recently Doll et al. (1994 In conclusion, there are at present 709 known offspring of survivors of childhood and adolescent leukaemia or nonHodgkin lymphoma, 382 from our study and 327 from previous studies, who have been followed up on average to at least 6 years of age. One of these offspring appears to have developed a disease similar to that successfully treated in her mother. Unfortunately, the original investigators were unable to contact the survivor concerned and are unable to confirm the clinical details of the disease in the offspring (Mulvihill et al., 1987) . From our study there is no evidence of an increased risk of malignant neoplasms among offspring as compared with the general population; it is unlikely that the risk is greater than the 8-fold expected. Furthermore, the proportion of survivors of childhood leukaemia and nonHodgkin lymphomas with the heritable form of these diseases is unlikely to exceed 5%, assuming an autosomal dominant mode of transmission with penetrance of 70-100%. More precise estimates of the heritable component of these diseases could be obtained by pooling the original data from this and previous studies and using similar methods of analysis to those adopted above.
The practical message to be derived from this and previous studies is that, although any detailed estimates of heritability depend on a number of unverified assumptions, and although a degree of caution is necessary until more offspring have been followed up, the empinrcally observed risks to offspring are small.
